Alzamend Neuro, Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Alzamend Neuro, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q1 2020 to Q1 2024.
  • Alzamend Neuro, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending April 30, 2024 was $10.8M, a 57.4% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $10.8M +$3.95M +57.4% Apr 30, 2024 10-K 2024-07-30
Q1 2023 $6.89M -$1.49M -17.8% Apr 30, 2023 10-K 2024-07-30
Q1 2022 $8.38M +$5.02M +149% Apr 30, 2022 10-K 2023-07-27
Q1 2021 $3.36M +$1.03M +44% Apr 30, 2021 10-K 2022-07-19
Q1 2020 $2.33M Apr 30, 2020 10-K 2021-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.